Clinical Trials Browser

Etoposide × Gynecologic × 1 year × Clear all

NCT02867956 2026-03-10

Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer

Phase 2 Completed

Ovarian Neoplasms

NCT07117877 2025-08-28

Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian Cancer

Phase 2 Not yet recruiting

Ovarian Neoplasms